Evidence map›Paper›PMID 29500613›Full record

ReviewDer Radiologe2018

[Radiological characterization of chronic inflammatory bowel disease].

H Schöllnast

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Radiologe, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

H SchöllnastUniversitätsklinik für Radiologie, Medizinische Universität Graz, Auenbruggerplatz 9, 8036, Graz, Österreich. helmut.schoellnast@medunigraz.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the course of the disease, chronic inflammatory bowel diseases (CIBD) show different activities, which-in addition to morphological changes-significantly influence the choice of therapy.

objectiveThe value of imaging in characterization of the activity of inflammatory changes is evaluated. MATERIALS AND

methodsIn the present review of the current literature, indications, performance, and findings of imaging of inflammatory bowel disease and on the assessment of disease activity are assessed.

resultsMagnetic resonance (MR) enterography allows the assessment of inflammatory bowel disease activity and subtyping.

conclusionIn addition to clinical, laboratory, and endoscopic information, MR enterography provides essential information for the assessment of CIBD activity.

Indexed as

Inflammatory Bowel DiseasesChronic DiseaseHumansMagnetic Resonance ImagingRadiographyClassificationCrohn diseaseDisease activityMagnetic resonance enterographyUlcerative colitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.